Episodes

Episode 340: Manipulating research for spinal manipulative therapy for low back pain  

In episode 340, Mike and James get all bent out of shape when they discuss the evidence around spinal manipulative therapy and low back pain. The evidence suggests no reliable effect for acute pain but the possibility of an effect for chronic pain. But any recommendations are a stretch because of the poor quality of the evidence. Show notes

Episode 339: All you need is glove, and tap water  

In episode 339, Mike and James talk about the evidence that has do with do with whether you need to use sterile gloves and saline for excisions and lacerations. The answer is that you should insert a suppository with the non-tapered end first.  Listen to the podcast and see how we come to that conclusion. Show notes 1) Tools for practice

Episode 338: Recurrent vulvovaginal candidiasis: Can the yeast be beat?  

In episode 338, Tina, Mike and James go over the best available evidence around the treatment for recurrent vulvovaginal candidiasis and we find that we can reduce relapse with regular use of azole antifungals or we could just treat when symptoms occur – guess what, it’s all up to patient preference. Oh, and treating the partner makes no difference. Show notes

Episode 336: A guide for where to draw the line on clinical practice guidelines – PART III  

In episode 336, James and Mike finish their review of clinical practice guidelines. We talk about how well clinicians and patients understand the benefits and harms of treatments and tests and then end with how the perfect clinical practice guideline should be written. Show notes

Episode 335: A guide for where to draw the line on clinical practice guidelines – PART II  

In episode 335, James and Mike continue their review of clinical practice guidelines. We discuss who writes the guidelines and if they mention values and preferences. At the end we let everyone know about the upcoming 28th annual BSM course on April 7/8, 2017 in Vancouver. Show notes

Episode 334: Santa Claus - is he more important to parents than children?  

In episode 334, Mike and James present the real evidence around a fictional, or is he, Santa Claus. We give everyone an evidence-based present wrapped in a systematic review. We discuss if Santa makes us kinder, and – SPOILER ALERT – when do children stop believing in Santa and does finding out scar them emotionally for life.  Show notes

Episode 333: A guide for where to draw the line on clinical practice guidelines  

In episode 333, James and Mike do a review of what we know about clinical practice guidelines. We discuss how guidelines are graded and what would make them awesome – and then reality sets in, quickly followed by depression. Show notes Handout

Episode 332: Erectile dysfunction - a hard look at the evidence – PART II  

In episode 332, James and Mike put a finishing touch on their upstanding erectile dysfunction discussion. We spend most of the podcast talking about treatments and options for ED and at the end we decide to never again be in the same room when talking about such a sensitive topic. Show notes See previous podcast

Episode 331: Erectile dysfunction - a hard look at the evidence  

In episode 331, James and Mike talk about the ups and downs of erectile dysfunction. We take a penetrating look at the epidemiology and what initial assessments should be done – treatments will pop-up in the next podcast. Fortunately or unfortunately, we rarely raise our comments above what would be expected from 14 year-old boys. Show notes

Episode 325: 1+1 =3 Numeracy and shared-decision making – PART II  

In episode 325, Mike and James continue their discussion about numbers and how to communicate risks. We discuss if people even want shared decisions and then if they do, what talk tools to use to facilitate that discussion.

Show notes

FRACTURES

read more

Episode 324:1+1 =3 Numeracy and shared-decision making  

In episode 324, Mike and James start a discussion about why numbers and our ability to communicate risks, benefits and harms to patients is crucial in today’s health care environment. Unfortunately, we find that many of us struggle with these concepts.

Show notes

Slides

Episode 323: LABA and steroids in asthma – is there any risk?  

In episode 323, James and Mike go over two new studies that have looked at the risk of using LABAs in combination with inhaled corticosteroids in both adults and children. Bottom line – no increased risk, but also not a lot of benefit either.

Show notes

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

read more

Episode 322: PrEP’d for HIV prevention  

In episode 322, Mike and James go over a new Tools for Practice that looked at the use of a combination product that may reduce the risk of HIV. It definitely seems to work but adherence is the key.

Show notes

Tools for Practice

read more

Episode 321: A couple of new studies that will confirm or change your practice  

In episode 321, James and Mike discuss two interesting studies. One is on the duration of antibiotics for community-acquired pneumonia and the other about the impact of total knee replacement on the overall quality of life. Interestingly, the results of these studies were different although that may have been the fact that one was on pneumonia and the other on TKR.

Show notes

read more

Episode 319: Listener questions and some questionable answers – PART IV  

In episode 319, Mike and James begin questioning the number of questions they are having to answer but plough forward and talk about confidence intervals, anticoagulation bridging, hormone replacement and finally bring it all home with comments on DRE. 

Show notes

read more

Episode 318: Listener questions and some questionable answers – PART III  

In episode 318, Mike and James attempt to answer even more questions. We run the spectrum from steroid injections, to repeat bone density measurements, to vortioxetine, generic drugs, and sitagliptin. Bottom line - please stop going to industry sponsored CME.

Show notes

1) Generic drugs

read more

Episode 317: Listener questions and some questionable answers – PART II  

In episode 317, James and Mike continue with their question and answering quest. We offer our spin on cardiovascular risk assessment, prostate screening, creatinine clearance and at the end leave our listeners questioning our podcast.

Show notes

1) Bridge Over Diagnosis - a parody of Bridge Over Troubled Water

read more

Episode 316: Listener questions and some questionable answers  

In episode 316, James and Mike finally get to the back-log of listener questions. We talk about stats, risk factors, guidelines and of course what podcast wouldn’t be complete without mentioning statins. 

Show notes

1) Critical appraisal by and for dummies – three podcast episodes

read more

Episode 315: A way to think about antidotes for anticoagulants - PART II  

In episode 315, James, Mike and Peter Loewen finish talking about the whole issue of antidotes for anticoagulants. In this podcast we focus on how we can have the conversation about these products with patients to allow for as much as possible, shared decision-making.

Show notes

Slides from Peter Loewen’s talk

read more

Episode 314: A way to think about antidotes for anticoagulants  

In episode 314, James and Mike welcome Peter Loewen back to the podcast to help us think through how we should frame the whole issue around antidotes for anticoagulants. At the end, we realise it is much more than just do we or do we not have an antidote.

Show notes

Slides from Peter Loewen’s talk

read more

0:00/0:00
Video player is in betaClose